Natural Killer Cell Activity and Response to Neoadjuvant Treatment in Breast Cancer Patients.

Int J Mol Sci · 2025 · PMC12609923 · PMID 41226397

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significancep = 0.07so close (0.05 < p ≤ 0.1)

The 5-year overall survival was 97.6% (95% CI 84.3–99.7%) and 85.7% (95% CI 53.9–96.2%) for normal and low NKA preoperatively, which did not reach statistical significance ( p = 0.07).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.